Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.

Cancer causes & control : CCC - 1 Feb 2009

Lurie Galina, Wilkens Lynne R, Thompson Pamela J, McDuffie Katharine E, Carney Michael E, Terada Keith Y, Goodman Marc T

Abstract excerpt

Ovarian cancer is influenced by exogenous and endogenous estrogens as suggested by experimental and epidemiological evidence. Estrogen receptor beta is a predominant estrogen receptor in the normal ovary. Polymorphisms in the estrogen receptor beta gene (ESR2) might influence epithelial ovarian risk through regulation of cell proliferation and apoptosis. This population-based case-control study included 313 women...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma

Share to Case-Control Studies

Share to Estrogen Receptor beta

Share to Genetic Predisposition to Disease

Share to Ovarian Neoplasms

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 18704709
DOI: 10.1007/s10552-008-9216-8
PMCID: PMC2663411

Genes

ESR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.PMID 18704709Read ↗

Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.Semantic proximity Read ↗

Association of estrogen receptor-beta (ESR2) polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer.Semantic proximity Read ↗

A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.Semantic proximity Read ↗

ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.Semantic proximity Read ↗

ESR2 gene variants (rs1256049, rs4986938, and rs1256030) and their association with breast cancer risk.Semantic proximity Read ↗

Estrogen receptor 1 (ESR1) genetic variations in cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Estrogen receptor alpha polymorphisms and the risk of malignancies.Semantic proximity Read ↗

Estrogen receptor polymorphisms and the risk of endometrial cancer.Semantic proximity Read ↗

Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study.Semantic proximity Read ↗

Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study.Semantic proximity Read ↗

Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.